Forbius

Pharmaceutical ManufacturingTexas, United States2-10 Employees

Forbius is a clinical-stage biopharmaceutical company based in Austin, Texas, focused on developing therapies for cancer and fibrotic diseases. It applies biological understanding and protein engineering to design inhibitors of the TGF-β and EGFR pathways, targets with established roles in serious illnesses.

Its work is oriented toward collaborations with researchers and clinicians pursuing targeted treatments for oncology and fibrosis. The company operates within the biopharmaceutical sector, emphasizing pathway-targeted therapeutics. In 2020, Bristol Myers Squibb acquired Forbius.

Sign up for free to view info

Email Format Employee directory